Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (211-220 of 392) with videos related to

Pageof 40
Sort By:
Blood|September 29, 2005
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemiaAmy Holleman, Monique L den Boer, Renée X de Menezes, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosisIrene L M Klaassen, Mandy N Lauw, Marta Fiocco, et al.
Pediatric Blood & Cancer|June 1, 2005
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemiaRobert D van Beek, Sabine M P F de Muinck Keizer-Schrama, Friederike G Hakvoort-Cammel, et al.
Haematologica|February 19, 2011
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)Gabriele Escherich, Anja Tröger, Ulrich Göbel, et al.
Blood|December 8, 2009
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L Den Boer, Pauline Schneider, et al.
Cancer Research|November 4, 2005
Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemiaSara Maia, W Nicholas Haining, Sascha Ansén, et al.
International Journal of Molecular Sciences|September 9, 2023
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in <i>KMT2A</i>-Rearranged Acute Lymphoblastic LeukemiaPauline Schneider, Priscilla Wander, Susan T C J M Arentsen-Peters, et al.
Haematologica|November 2, 2018
Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemiaRoel Polak, Marc B Bierings, Cindy S van der Leije, et al.
International Immunology|April 26, 2006
Contributions of mucosal immune cells to methotrexate-induced mucositisBarbara A E de Koning, Jolanda M van Dieren, Dicky J Lindenbergh-Kortleve, et al.
Haematologica|July 18, 2024
No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 studyValentino Conter, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Pageof 40

Showing results (211-220 of 392) with videos related to

Sort By:
Pageof 40
Blood|September 29, 2005
The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemiaAmy Holleman, Monique L den Boer, Renée X de Menezes, et al.
Research and Practice in Thrombosis and Haemostasis|April 24, 2019
Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosisIrene L M Klaassen, Mandy N Lauw, Marta Fiocco, et al.
Pediatric Blood & Cancer|June 1, 2005
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemiaRobert D van Beek, Sabine M P F de Muinck Keizer-Schrama, Friederike G Hakvoort-Cammel, et al.
Haematologica|February 19, 2011
The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)Gabriele Escherich, Anja Tröger, Ulrich Göbel, et al.
Blood|December 8, 2009
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemiaRonald W Stam, Monique L Den Boer, Pauline Schneider, et al.
Cancer Research|November 4, 2005
Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemiaSara Maia, W Nicholas Haining, Sascha Ansén, et al.
International Journal of Molecular Sciences|September 9, 2023
CRISPR-Cas9 Library Screening Identifies Novel Molecular Vulnerabilities in <i>KMT2A</i>-Rearranged Acute Lymphoblastic LeukemiaPauline Schneider, Priscilla Wander, Susan T C J M Arentsen-Peters, et al.
Haematologica|November 2, 2018
Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemiaRoel Polak, Marc B Bierings, Cindy S van der Leije, et al.
International Immunology|April 26, 2006
Contributions of mucosal immune cells to methotrexate-induced mucositisBarbara A E de Koning, Jolanda M van Dieren, Dicky J Lindenbergh-Kortleve, et al.
Haematologica|July 18, 2024
No clear benefit of preventive cranial radiotherapy in childhood Philadelphia-positive acute lymphoblastic leukemia: a retrospective analysis of the EsPhALL2010 studyValentino Conter, Maria Grazia Valsecchi, Paola De Lorenzo, et al.
Pageof 40